Display Settings:

Format

Send to:

Choose Destination
    RNA. 2007 Jul;13(7):1132-9. Epub 2007 May 25.

    Depletion of newly synthesized Argonaute1 impairs the RNAi response in Trypanosoma brucei.

    Source

    Department of Internal Medicine, Yale University Medical School, New Haven, CT 06536-0812, USA.

    Abstract

    In Trypanosoma brucei, Argonaute1 (TbAGO1) is an essential component of the RNA interference (RNAi) pathway. While characterizing a TbAGO1 conditional knockout cell line, we discovered that, upon blockage of TbAGO1 transcription, the RNAi response to transfected double-stranded RNA was severely inhibited, although there was no change in the TbAGO1 protein level. This observation suggested that steady-state TbAGO1 was not sufficient to fully support the RNAi response to transfected dsRNA and implicated newly synthesized Argonaute in this phenomenon. Indeed, a translational blockade of TbAGO1 mRNA with an antisense morpholino oligonucleotide resulted in inhibition of the RNAi response, even though the steady-state level of TbAGO1 remained unchanged during the time of the assay. Thus, we concluded that in T. brucei, newly synthesized TbAGO1 is required to support an efficient RNAi response. We speculate that newly processed siRNAs may be preferentially loaded onto newly synthesized TbAGO1, and this mechanism may contribute to the homeostasis of the RNAi pathway.

    PMID:
    17526643
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1894921
    Free PMC Article

    Images from this publication.See all images (5) Free text

    FIGURE 1.
    FIGURE 3.
    FIGURE 5.
    FIGURE 2.
    FIGURE 4.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk